A citation-based method for searching scientific literature

Aaron C Tan, Daniel S W Tan. J Clin Oncol 2022
Times Cited: 12







List of co-cited articles
41 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.
Ferdinandos Skoulidis, John V Heymach. Nat Rev Cancer 2019
254
33

The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Nadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A Cronin, Angela B Mariotto, Douglas R Lowy, Eric J Feuer. N Engl J Med 2020
339
25


The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
25

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
Suresh S Ramalingam, Johan Vansteenkiste, David Planchard, Byoung Chul Cho, Jhanelle E Gray, Yuichiro Ohe, Caicun Zhou, Thanyanan Reungwetwattana, Ying Cheng, Busyamas Chewaskulyong,[...]. N Engl J Med 2020
829
25

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw, Kari Chansky, John Crowley, Ramon Rami-Porta, Hisao Asamura, Wilfried E E Eberhardt, Andrew G Nicholson, Patti Groome, Alan Mitchell, Vanessa Bolejack. J Thorac Oncol 2016
25

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Enriqueta Felip, Nasser Altorki, Caicun Zhou, Tibor Csőszi, Ihor Vynnychenko, Oleksandr Goloborodko, Alexander Luft, Andrey Akopov, Alex Martinez-Marti, Hirotsugu Kenmotsu,[...]. Lancet 2021
91
16

First-Line Immunotherapy for Non-Small-Cell Lung Cancer.
Martin Reck, Jordi Remon, Matthew D Hellmann. J Clin Oncol 2022
11
18


The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.
Min Yuan, Li-Li Huang, Jian-Hua Chen, Jie Wu, Qing Xu. Signal Transduct Target Ther 2019
185
16


Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).
Masahiro Fukuoka, Yi-Long Wu, Sumitra Thongprasert, Patrapim Sunpaweravong, Swan-Swan Leong, Virote Sriuranpong, Tsu-Yi Chao, Kazuhiko Nakagawa, Da-Tong Chu, Nagahiro Saijo,[...]. J Clin Oncol 2011
16

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.
Badi El Osta, Madhusmita Behera, Sungjin Kim, Lynne D Berry, Gabriel Sica, Rathi N Pillai, Taofeek K Owonikoko, Mark G Kris, Bruce E Johnson, David J Kwiatkowski,[...]. J Thorac Oncol 2019
82
16


Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status.
Biagio Ricciuti, Kathryn C Arbour, Jessica J Lin, Amir Vajdi, Natalie Vokes, Lingzhi Hong, Jianjun Zhang, Michael Y Tolstorukov, Yvonne Y Li, Liam F Spurr,[...]. J Thorac Oncol 2022
22
16

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Sara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi, Massimiliano Grassi, Veronica Murianni, Marco Tagliamento, Arsela Prelaj, Simona Coco, Luca Longo, Maria Giovanna Dal Bello,[...]. Int J Mol Sci 2021
12
16

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.
Andrew G Nicholson, Ming S Tsao, Mary Beth Beasley, Alain C Borczuk, Elisabeth Brambilla, Wendy A Cooper, Sanja Dacic, Deepali Jain, Keith M Kerr, Sylvie Lantuejoul,[...]. J Thorac Oncol 2022
27
16

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, Matthew D Hellmann, Mark M Awad, Justin F Gainor, Alexa B Schrock, Ryan J Hartmaier, Sally E Trabucco, Laurie Gay,[...]. Cancer Discov 2018
674
16

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain,[...]. J Clin Oncol 2021
80
16

KRAS Mutations in Squamous Cell Carcinomas of the Lung.
Fabian Acker, Jan Stratmann, Lukas Aspacher, Ngoc Thien Thu Nguyen, Sebastian Wagner, Hubert Serve, Peter J Wild, Martin Sebastian. Front Oncol 2021
4
50

Fusion-positive non-small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications.
Daniel Kazdal, Véronique Hofman, Petros Christopoulos, Marius Ilié, Albrecht Stenzinger, Paul Hofman. Genes Chromosomes Cancer 2022
4
50

Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
Denis Horgan, Giuseppe Curigliano, Olaf Rieß, Paul Hofman, Reinhard Büttner, Pierfranco Conte, Tanja Cufer, William M Gallagher, Nadia Georges, Keith Kerr,[...]. J Pers Med 2022
7
28

Clinical utility of reflex testing using focused next-generation sequencing for management of patients with advanced lung adenocarcinoma.
Tyler E Miller, Michael Yang, David Bajor, Judah D Friedman, Richard Y C Chang, Afshin Dowlati, Joseph E Willis, Navid Sadri. J Clin Pathol 2018
21
16


The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas.
Baharia Mograbi, Simon Heeke, Paul Hofman. Diagnostics (Basel) 2021
11
18

Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review.
Rossella Bruno, Gabriella Fontanini. Diagnostics (Basel) 2020
34
16

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.
Keith M Kerr, Frédéric Bibeau, Erik Thunnissen, Johan Botling, Aleš Ryška, Jürgen Wolf, Katarina Öhrling, Peter Burdon, Umberto Malapelle, Reinhard Büttner. Lung Cancer 2021
33
16

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
F Mosele, J Remon, J Mateo, C B Westphalen, F Barlesi, M P Lolkema, N Normanno, A Scarpa, M Robson, F Meric-Bernstam,[...]. Ann Oncol 2020
221
16

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
16

Two Patients With Advanced-Stage Lung Adenocarcinoma With Radiologic Complete Response to Nivolumab Treatment Harboring an STK11/LKB1 Mutation.
Ernest Nadal, Simon Heeke, Jonathan Benzaquen, Noelia Vilariño, Arturo Navarro, Daniel Azuara, Mar Varela, Josiane Otto, Nuria Baixeras, David Shahbazian,[...]. JCO Precis Oncol 2020
2
100

The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer.
Barbara Melosky, Paul Wheatley-Price, Rosalyn A Juergens, Adrian Sacher, Natasha B Leighl, Ming-Sound Tsao, Parneet Cheema, Stephanie Snow, Geoffrey Liu, Paul B Card,[...]. Lung Cancer 2021
13
16

Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.
Marco H Hofmann, Daniel Gerlach, Sandra Misale, Mark Petronczki, Norbert Kraut. Cancer Discov 2022
8
25

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
675
16


Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer.
E Heitzer, D van den Broek, M G Denis, P Hofman, M Hubank, F Mouliere, L Paz-Ares, E Schuuring, H Sültmann, G Vainer,[...]. ESMO Open 2022
7
28

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Nasser H Hanna, Bryan J Schneider, Sarah Temin, Sherman Baker, Julie Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain,[...]. J Clin Oncol 2020
139
16

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
J Mazieres, A Drilon, A Lusque, L Mhanna, A B Cortot, L Mezquita, A A Thai, C Mascaux, S Couraud, R Veillon,[...]. Ann Oncol 2019
397
16

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Janette Greenhalgh, Angela Boland, Victoria Bates, Fabio Vecchio, Yenal Dundar, Marty Chaplin, John A Green. Cochrane Database Syst Rev 2021
11
18

Lung cancer.
Alesha A Thai, Benjamin J Solomon, Lecia V Sequist, Justin F Gainor, Rebecca S Heist. Lancet 2021
112
16

Lung cancer: current therapies and new targeted treatments.
Fred R Hirsch, Giorgio V Scagliotti, James L Mulshine, Regina Kwon, Walter J Curran, Yi-Long Wu, Luis Paz-Ares. Lancet 2017
16

Managing Central Nervous System Spread of Lung Cancer: The State of the Art.
David Chun Cheong Tsui, D Ross Camidge, Chad G Rusthoven. J Clin Oncol 2022
2
50

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Paul Baas, Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto, Solange Peters, Anne S Tsao, Aaron S Mansfield, Sanjay Popat, Thierry Jahan, Scott Antonia,[...]. Lancet 2021
256
8

Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer.
Jeffrey A Bogart, Saiama N Waqar, Michael D Mix. J Clin Oncol 2022
3
33

New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.
Anne S Tsao, Harvey I Pass, Andreas Rimner, Aaron S Mansfield. J Clin Oncol 2022
2
50

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2018
8

Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies.
Antonio Passaro, Julie Brahmer, Scott Antonia, Tony Mok, Solange Peters. J Clin Oncol 2022
5
20

Systemic and Radiation Therapy Approaches for Locally Advanced Non-Small-Cell Lung Cancer.
Kristin A Higgins, Sonam Puri, Jhanelle E Gray. J Clin Oncol 2022
2
50

Patient-Centered Palliative Care for Patients With Advanced Lung Cancer.
Jennifer S Temel, Laura A Petrillo, Joseph A Greer. J Clin Oncol 2022
2
50

Practical Management of Oligometastatic Non-Small-Cell Lung Cancer.
Katie Jasper, Brendon Stiles, Fiona McDonald, David A Palma. J Clin Oncol 2022
1
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.